BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35687966)

  • 1. Evaluation and external validation of minor lymphatic pelvic pathway for distant metastases in cervical cancer patients treated with concurrent chemoradiotherapy.
    Thephamongkhol K; Korpraphong P; Muangsomboon K; Sitathanee C; Lertkhachonsuk AA; Phongkitkarun S; Srirattanapong S; Prapruttam D; Bridhikitti J; Dendumrongsup T; Alisanant P; Amornwichet N; Khorprasert C; Sasiwimonphan K; Tanprasertkul C; Dhanachai M; Patumanond J; Setakornnukul J
    Curr Probl Cancer; 2022 Aug; 46(4):100876. PubMed ID: 35687966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic prediction model including the minor lymphatic pathway for distant metastases in cervical cancer patients.
    Thephamongkhol K; Korpraphong P; Muangsomboon K; Sitathanee C; Lertkhachonsuk AA; Phongkitkarun S; Srirattanapong S; Prapruttam D; Bridhikitti J; Dendumrongsup T; Alisanant P; Amornwichet N; Khorprasert C; Sasiwimonphan K; Tanprasertkul C; Dhanachai M; Patumanond J; Setakornnukul J
    Sci Rep; 2022 Jun; 12(1):9873. PubMed ID: 35701437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
    Wang R; Tao X; Wu X; Jiang H; Xia H
    J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].
    Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer.
    Kasuya G; Toita T; Furutani K; Kodaira T; Ohno T; Kaneyasu Y; Yoshimura R; Uno T; Yogi A; Ishikura S; Hiraoka M
    Radiat Oncol; 2013 Jun; 8():139. PubMed ID: 23758698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer.
    Widschwendter P; Janni W; Scholz C; De Gregorio A; De Gregorio N; Friedl TWP
    Arch Gynecol Obstet; 2019 Dec; 300(6):1709-1718. PubMed ID: 31696367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis.
    Peters M; de Leeuw AAC; Nomden CN; Tanderup K; Kirchheiner K; Lindegaard JC; Kirisits C; Haie-Meder C; Sturdza A; Fokdal L; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Tan LT; van Rossum PSN; Nesvacil N; Nout R; Schmid MP; Pötter R; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2021 Oct; 163():150-158. PubMed ID: 34480958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    PLoS One; 2019; 14(4):e0214498. PubMed ID: 30986236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
    Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort.
    Endo D; Todo Y; Okamoto K; Minobe S; Kato H; Nishiyama N
    J Gynecol Oncol; 2015 Jan; 26(1):12-8. PubMed ID: 25310853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system.
    Machida H; Matsuo K; Kobayashi Y; Momomura M; Takahashi F; Tabata T; Kondo E; Yamagami W; Ebina Y; Kaneuchi M; Nagase S; Mikami M
    J Gynecol Oncol; 2022 May; 33(3):e26. PubMed ID: 35320882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
    Lee JM; Lee KB; Lee SK; Park CY
    J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the Treatment of Cervical Cancer with Bulky Pelvic Lymph Nodes: An Overview of the Current Evidence.
    Tohyama A; Murakami M; Yoshino K
    J UOEH; 2020; 42(4):317-325. PubMed ID: 33268608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence and influencing factors of distal external iliac lymph node metastasis in early cervical cancer].
    Yin Y; Sheng X; Li X; Li D; Han X; Zhang X; Zhang T
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):457-60. PubMed ID: 25241790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
    Fischerová D; Cibula D
    Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2-IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review.
    Kuji S; Hirashima Y; Komeda S; Tanaka A; Abe M; Takahashi N; Takekuma M; Asakura H; Harada H; Nishimura T
    Int J Clin Oncol; 2014 Apr; 19(2):341-7. PubMed ID: 23546545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis.
    Pinto PJJ; Chen MJ; Santos Neto E; Faloppa CC; De Brot L; Guimaraes APG; da Costa AABA; Baiocchi G
    Int J Gynecol Cancer; 2022 Mar; 32(3):239-245. PubMed ID: 35256409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.